IRMS - Nicolae Testemitanu SUMPh: Recent submissions

  • Use of sodium-glucose cotransporter 2 inhibitors in heart failure 
    Ferdohleb, Alexandrina (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Heart failure syndrome has been designated as a major clinical and public health problem. Ischemic cardiopathy, arterial hypertension, cardiomyopathies, myocarditis, pericarditis valvulopathies, arrhythmias, ...
  • Study on clinical cases of atopic dermatitis in children 
    Iepure, Maria (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Allergic contact dermatitis (ACD) was once considered a rarity in children, but recent estimates suggest that it affects 4.4 million children in the United States alone. Currently, there is no cure, but an ...
  • Comparative analysis of the national and international legislative framework regarding the storage of medicinal products for human use 
    Golovei, Ina; Adauji, Stela (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Globally, regulating and managing medicines is vital for public health. This presentation compares how the Republic of Moldova and the European Union handle the storage and preservation of medicines. It ...
  • Antibacterial activity of basil essential oil 
    Boguș, Dorin (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Basil essential oil has been demonstrated to possess various beneficial properties, including analgesic, anti-inflammatory, antibacterial, hepatoprotective, and immunomodulatory effects. The multifunctionality ...
  • Action of biopharmaceutical factors on drug bioavailability 
    Andronachi, Gabriela (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. According to the Food and Drug Administration (FDA), bioavailability represents the amount of active substance released from a pharmaceutical form, absorbed into the bloodstream, and reaching the site of ...
  • Drug interactions and errors in the treatment of hypertension in the elderly 
    Diaconu, Ion (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Hypertension is a condition in which the systolic and diastolic pressures are increased above the permissible limit. According to the European Society of Hypertension, for people without diabetes, the values ...
  • Liposome biopharmaceutic and nanoparticles in human body 
    Costea, Anastasia (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. The use of nanotechnology in medicine, and more specifically in drug delivery, is rapidly spreading. Numerous substances are currently being researched for drug delivery and, in particular, cancer therapy. Aim ...
  • Borderline personality disorder in children and adolescents 
    Tapu, Andreea (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Borderline personality disorder is one of the most common psychiatric diseases worldwide. The clinical features of the disorder vary a lot depending on age, onset, gender, social status, and other comorbidities. ...
  • Anorexia and bulimia nervosa 
    Tatarciuc, Vlada (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction: Eating disorders, which are mentally debilitating, life-threatening, and financially burdensome conditions, significantly compromise physical well-being and disrupt psychosocial functionality. Current ...
  • Depression and anxiety in patients with epilepsy 
    Filimon, Maria; Vasilieva, Maria; Titorog, Tudor (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Depressive, anxious and other mood disorders are factors that, along with epileptic seizures, complicate the course of epilepsy and prevent full recovery of patient health even when remission is achieved ...
  • Diet and depression 
    Rotarciuc, Jana (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Depression is a mental disorder which is characterized by losing pleasure, mood or interest in activities usually for a long period of time. According to the World Health Organization approximately 280 million ...
  • Training of abdominal breathing on purpose of reducing anxiety by restricting the chest movements 
    Muntean, Elizaveta (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. The respiratory biofeedback method is based on executing of paced voluntary respiratory movements in order to reeducate a dysfunctional breathing pattern into a physiologically normal one. Respiratory biofeedback ...
  • Diagnostic criteria of suicidal and parasuicidal behavior 
    Donea, Carolina (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Suicide behavior represents a totality of behaviors from suicide attempt to completed suicide. While, parasuicidal behavior is characterized by “any non-fatal, serious, deliberate self-harm with or without ...
  • Attention-deficit/hyperactivity disorder in adults 
    Țapeș, Victoria (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that affects both children and adults. It is characterized by symptoms such as inattention, hyperactivity, and impulsivity. Aim ...
  • Depression in schizophrenia 
    Hiora, Sofia (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Schizophrenia is a mental disorder with pronounced symptoms in the form of mental disturbances, difficulties in communication, emotional reactivity and difficulty perceiving reality. Depression is a mood ...
  • Autism spectrum disorder screening in primary care 
    Carpineanu, Antonella (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Autism Spectrum Disorder (ASD) is characterized by a series of deficits that originate in the first two years of life, including deficits in verbalization, socialization, and stereotypical behavior. ASD ...
  • Gluten intolerance. Celiac disease 
    Volc, Renata (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Celiac disease (CD) is an immune-mediated inflammatory condition of the small intestine that occurs in genetically predisposed individuals when they are exposed to gluten (a plant-based protein component found ...
  • The influence of type 2 pregestational diabetes mellitus on the fetus 
    Surlaru, Valeria (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. The prevalence of type 2 diabetes among women of reproductive age is increasing. According to the latest data from the International Diabetes Federation in 2019, one in six live births is affected by hyperglycemia ...
  • The role of gut microbiota metabolites in atherosclerosis 
    Berliba, Marina (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Changes in gut microbiota metabolites(GMM) is linked to the development of CVD, which includes atherosclerosis, hypertension, ...
  • Mechanisms of action and metabolic effects of anticoagulants 
    Curelariu, Mădălina; Stratulat, Silvia (Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova, 2024)
    Introduction. Anticoagulant drugs antagonize coagulation and are used to prevent or prolong the clotting time. Nowadays physicians from different fields possess a broad panel of multiple anticoagulants to meet a patient's ...